ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Thermo Fisher Scientific has signed a definitive agreement to acquire the bioprocessing business of medical technology firm Becton, Dickinson & Co. The acquisition, for an undisclosed amount, will give Thermo Fisher a business that provides peptones to biopharmaceutical customers to enhance cell culture media formulations. Thermo Fisher says the business, which has about $100 million in annual sales, will complement its existing bioproduction offerings. The deal is expected to close in early 2019.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter